Back

The most important safety risk of fish oil from the latest meta-analysis?

7 April 2022 (17:05 - 17:14)
Organised by:
Congress Presentation Part of: Moderated posters session 1 - Secondary Prevention and Rehabilitation Drug therapy EAPC Premium Access ESC Preventive Cardiology 2022

About the speaker

Photo
Doctor Jie Yan

(China)

4 More presentations in this session

Presentation thumbnail
The efficacy of high-load resistance training in combination with aerobic training in patients with coronary artery disease: a dose-dependent randomised, controlled clinical trial
Mr T. Kambic (Ljubljana, SI)
Abstract Slides
Presentation thumbnail
Exercise training modalities for heart transplant recipients: A systematic review and network meta-analysis
Presentation thumbnail
Novel equation for skeletal muscle mass estimation is useful for predicting mortality in patients with heart failure
Mr S. Honma (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Overall benefits of smoking cessation in patients with ASCVD are underestimated
Ms T. Van Trier (Amsterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Moderated posters session 1 - Secondary Prevention and Rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2022

7 April 2022 17:05 CET
You may be interested in
thumbnail
Congress Presentation
Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial
27 August 2021
thumbnail
Congress Presentation
Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials.
1 September 2019
thumbnail
Congress Presentation
Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis
1 September 2025
thumbnail
Congress Presentation
A meta-analysis on the efficacy of influenza vaccine in reducing cardiovascular mortality and myocardial infarction in patients with cardiovascular disease
3 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources